arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Atossa Therapeutics, Inc.

ATOS Health Care Biotechnology: Pharmaceutical Preparations
$2.72
▲ +7.1% Today
as of Oct 23, 09:16 ET
Last 30 days +9.68% Sep 14 → Oct 22
$1.82 $2.11 $2.41 $2.70 $2.99 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$2.46
High
$2.76
Low
$2.46
Volume
$90,585
Avg Vol
$106,126
Mkt Cap
$23M
P/E (TTM)
—
Beta
—
52w High
$14.85
52w Low
$1.70
Div Yield
—
Shares Out
$10M

Recent Press Releases & News last 60 days · 5 items

Oct 19 · 12:00 PR PR Newswire
Atossa Therapeutics Common Stock to Begin Trading with Stapled Contingent Value Rights After Close of Business Today
Oct 9 · 12:00 PR PR Newswire
Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation in Potential Priority Review Voucher Value
Sep 30 · 17:18 Pharmaceutical Technology
Atossa plans shareholder stake in potential PRV proceeds
▸ Show all 5 press releases & news Free account →

ATOS earnings at a glance

The options market is pricing a move of about ±55.8% after the report, a range of roughly $1.20 to $4.24 from today's $2.72. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±3.6% on average; after the most recent report on May 8, 2026 it moved -1.2%. That means options currently expect more movement than ATOS has typically delivered. ATOS beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 472%. The share price of $2.72 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.70
$15
8% of range
Avg surprise (last 4)
+2.3%
Avg reaction (last 2)
+2.4%
50% positive
Latest IV / EM
472%
EM ±55.8% · $2 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.22$-0.93$-0.64$-0.34$-0.05 Actual $-0.05Actual $-0.08Actual $-0.05Actual $-0.05Actual $-0.05Actual $-0.06Actual $-0.05Est $-0.06Actual $-0.07Est $-0.06Actual $-0.07Est $-0.07Actual $-1.11Est $-1.22Actual $-0.95 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-10M$-9M$-8M$-8M$-7M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.95 — — — — financials
Fri May 8, 2026Mar/2026 $-1.11 $-1.22 +9.0% -2,120% -1.2% earnings
Wed Nov 12, 2025Sep/2025 $-0.07 $-0.07 0.0% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.07 $-0.06 -16.7% — — earnings
Tue May 13, 2025Mar/2025 $-0.05 $-0.06 +16.7% — +6.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.06 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.05 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.05 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.05 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.08 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.05 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-9M$-10M—$-9M$-9M$-7M—$-6M
Net income$-8M$-10M—$-9M$-8M$-7M—$-7M
EPS (diluted)$-0.95$-1.11—$-0.07$-0.98$-0.78—$-0.06

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$26M$32M$41M$52M$58M$65M$71M$75M
Inventory————————
Total current assets$31M$37M$46M$56M$63M$69M$74M$77M
Total assets$32M$38M$48M$58M$65M$71M$76M$79M
Long-term debt————————
Total liabilities$5M$7M$8M$8M$7M$5M$5M$6M
Total equity$27M$30M$39M$50M$58M$65M$71M$74M

Implied volatility — last 90 days

72%361%649%938%1226% Jun 07 — IV 291% · EM ±40.3%Jun 08 — IV 158% · EM ±20.9%Jun 09 — IV 186% · EM ±23.2%Jun 10 — IV 231% · EM ±27.3%Jun 11 — IV 122% · EM ±13.5%Jun 12 — IV 360% · EM ±36.8%Jun 17 — IV 1226% · EM ±51.2%Jun 19 — IV 259% · EM ±57.2%Jun 22 — IV 118% · EM ±24.6%Jun 23 — IV 103% · EM ±21.0%Jun 26 — IV 153% · EM ±29.3%Jun 29 — IV 185% · EM ±32.8%Jun 30 — IV 98% · EM ±16.8%Jul 01 — IV 213% · EM ±35.5%Jul 02 — IV 73% · EM ±11.8%Jul 03 — IV 75% · EM ±11.8%Jul 06 — IV 222% · EM ±30.7%Jul 08 — IV 277% · EM ±34.7%Jul 09 — IV 323% · EM ±38.1%Jul 10 — IV 477% · EM ±52.7%Jul 13 — IV 549% · EM ±45.8%Jul 15 — IV 382% · EM ±22.5%Jul 20 — IV 212% · EM ±50.2%Jul 21 — IV 121% · EM ±28.1%Jul 22 — IV 216% · EM ±49.4%Jul 23 — IV 203% · EM ±45.6%Jul 27 — IV 172% · EM ±36.0%Jul 28 — IV 202% · EM ±41.4%Jul 30 — IV 157% · EM ±30.8%Aug 10 — IV 305% · EM ±42.2%Aug 11 — IV 353% · EM ±46.6%Aug 24 — IV 113% · EM ±23.7%Aug 25 — IV 210% · EM ±42.9%Aug 26 — IV 113% · EM ±22.6%Aug 27 — IV 232% · EM ±45.5%Aug 28 — IV 217% · EM ±41.5%Aug 31 — IV 237% · EM ±42.0%Sep 01 — IV 276% · EM ±47.5%Sep 02 — IV 256% · EM ±42.7%Sep 03 — IV 293% · EM ±47.4%Sep 04 — IV 292% · EM ±45.6%Sep 07 — IV 329% · EM ±45.6%Sep 08 — IV 331% · EM ±43.7%Sep 10 — IV 380% · EM ±44.9%Sep 11 — IV 451% · EM ±49.8%Sep 14 — IV 531% · EM ±44.4%Sep 15 — IV 525% · EM ±38.0%Sep 21 — IV 234% · EM ±48.9%Sep 22 — IV 227% · EM ±46.5%Sep 23 — IV 206% · EM ±41.3%Sep 24 — IV 261% · EM ±51.2%Sep 25 — IV 76% · EM ±14.5%Sep 28 — IV 115% · EM ±20.4%Sep 29 — IV 321% · EM ±55.3%Oct 01 — IV 313% · EM ±50.7%Oct 02 — IV 342% · EM ±53.4%Oct 06 — IV 386% · EM ±51.0%Oct 07 — IV 406% · EM ±50.8%Oct 08 — IV 472% · EM ±55.8%

Sector peers

COCP
Cocrystal Pharma, Inc.
$22M $0.91-3.0%
SNSE
Sensei Biotherapeutics, Inc.
$24M $13.85
BRNS
Barinthus Biotherapeutics plc
$25M $0.74-2.5%
RGNT
Regentis Biomaterials Ltd.
$20M $1.40-4.8%
KYNB
Kyntra Bio, Inc.
$26M $5.22-1.1%
ABVC
ABVC Biopharma, Inc.
$27M $1.05+12.6%

ATOS earnings FAQ

What is ATOS's expected move for earnings?

Options currently price a move of about ±55.8%, or $1.52 per share either way from $2.72.

How does ATOS stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.6%, up 1 times and down 1 times.

What is ATOS's implied volatility?

ATOS's at-the-money implied volatility is about 472% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in